bumetanide has been researched along with Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lozovaya, N | 1 |
| Nardou, R | 1 |
| Tyzio, R | 1 |
| Chiesa, M | 1 |
| Pons-Bennaceur, A | 1 |
| Eftekhari, S | 1 |
| Bui, TT | 1 |
| Billon-Grand, M | 1 |
| Rasero, J | 1 |
| Bonifazi, P | 1 |
| Guimond, D | 1 |
| Gaiarsa, JL | 1 |
| Ferrari, DC | 1 |
| Ben-Ari, Y | 1 |
| Bou Khalil, R | 1 |
2 other studies available for bumetanide and Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome
| Article | Year |
|---|---|
Early alterations in a mouse model of Rett syndrome: the GABA developmental shift is abolished at birth.
Topics: Animals; Bumetanide; gamma-Aminobutyric Acid; Methyl-CpG-Binding Protein 2; Mice; Mice, Inbred C57BL | 2019 |
Is insulin growth factor-1 the future for treating autism spectrum disorder and/or schizophrenia?
Topics: Animals; Autism Spectrum Disorder; Brain; Bumetanide; Child; Child, Preschool; Chlorides; Endocannab | 2017 |